Researchers at Yale University medical school say the placenta may yield clues to problems that lead to onset of autism, a developmental disorder.
The findings, reported in the June 26 online issue of Biological Psychiatry, could help physicians diagnose the condition at birth rather than the age of 2 or older, the school said in an announcement.
In most cases, the researchers say autism sets in early in infancy, but information regarding this has been limited. They say the earlier a diagnosis is made, the greater the treatment impact.
The ideal time for diagnosis would be at birth, says Dr. Harvey Kliman, the study's lead author. In previous work, he had observed an unusual pathologic finding in the placentas from children with Asperger Syndrome, an ASD condition which, like autism, impairs the ability to relate to others, the announcement said.
"By serendipity, at a dinner party I happened to sit next to George M. Anderson, a research scientist in the Yale Child Study Center who had access to many cases of children with ASD," said Kliman. "We realized that by working together we might be able to determine if this placental abnormality could be a useful clinical marker."
The Yale team plans to replicate the evaluation with larger multi-center and prospective studies.
Copyright 2006 by United Press International
Related stories:
Researchers move 2 steps closer to understanding genetic underpinnings of autism
Today’s issue of the
American Journal of Human Genetics (AJHG), describes what might be a corner piece of the autism puzzle—the identification and subsequent validation of a gene linked to the development of autism by three separate groups of scientists. An accompanying commentary by Dr. Dietrich Stephan, Director of the Neurogenomics Division at the Translational Genomics Research Institute’s (TGen), further explains the findings.
Researchers Identify Autism Gene
Yale School of Medicine autism experts Fred Volkmar, M.D. and Ami Klin are part of a global research consortium from 19 countries to identify a gene and a region of a chromosome that may lead to autism in children.
Toddlers' focus on mouths rather than on eyes is a predictor of autism severity
Scientists at Yale School of Medicine have found that two-year-olds with autism looked significantly more at the mouths of others, and less at their eyes, than typically developing toddlers. This abnormality predicts the level of disability, according to study results published in the
Archives of General Psychiatry.
Patterns of normal brain activity may predispose individuals to different symptoms of psychosis
A new study released today offers a potential predictive technique to anticipate how individuals might behave during a psychotic episode. The study, in the June 18 issue of
The Journal of Neuroscience, related the brain activity of healthy participants to how they behaved after exposure to ketamine (a psychosis-inducing drug that mimics schizophrenia symptoms). The findings help explain why schizophrenia symptoms vary greatly from person to person and may ultimately help personalize diagnosis and intervention.
Pharaoh's Unusual Feminine Appearance Suggests Two Gene Defects
The feminine features and elongated head of ancient Egypt’s King Akhenaten may be attributed to two genetic defects called aromatose excess syndrome and craniosynostosis, said Yale School of Medicine dermatology professor Irwin Braverman, M.D.
Genetic links to impaired social behavior in autism
Individuals with autism spectrum disorders (ASD) show profound deficits in social interactions and communications, and display repetitive behaviors and abnormal responses to sensory experiences. One aspect of an autistic child’s impaired social abilities is their lack of affiliative behaviors, i.e., behaviors such as touching and hugging that strengthen social bonds. On May 15th,
Biological Psychiatry is publishing an article that reports new findings on genetic bases of these behaviors.
Improving anxiety treatment through the help of brain imaging: A potential future treatment strategy
Wouldn’t it be nice if our doctors could predict accurately whether we would respond to a particular medication? This question is important because research studies provide information about how groups of patients tend to respond to treatments, but inevitably, differences among groups of patients with the same diagnosis mean that findings about groups of patients may not apply to individuals from those groups.
Racial disparities persist in cancer care
A new study finds that, despite efforts in the last decade to mitigate cancer treatment disparities, black patients are significantly less likely than white patients to receive therapy for various types of cancer. The authors of the study conclude that efforts to close treatment gaps initiated in the 1990s appear to have had little impact. The report appears in the February 15, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.